Octahedral molybdenum clusters as radiosensitizers for X-ray induced photodynamic therapy
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388980%3A_____%2F18%3A00491206" target="_blank" >RIV/61388980:_____/18:00491206 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/68378271:_____/18:00491206 RIV/68407700:21340/18:00328132 RIV/60461373:22330/18:43916976
Výsledek na webu
<a href="http://dx.doi.org/10.1039/c8tb00893k" target="_blank" >http://dx.doi.org/10.1039/c8tb00893k</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/c8tb00893k" target="_blank" >10.1039/c8tb00893k</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Octahedral molybdenum clusters as radiosensitizers for X-ray induced photodynamic therapy
Popis výsledku v původním jazyce
The use of radiosensitizers recently emerged as a promising approach to circumvent the depth penetration limitations of photodynamic therapy of cancer and to enhance radiotherapeutical effects. A widely explored current strategy is based on complex nanoarchitectures that facilitate the transfer of energy harvested from X-ray radiation by scintillating nanoparticles to the surrounding photosensitizer molecules to generate reactive oxygen species, mostly singlet oxygen O-2((1)Delta(g)). We describe an alternative approach aiming at a considerable simplification of the architecture. The presented nanoparticles, made of the luminescent octahedral molybdenum cluster compound (n-Bu4N)(2)[Mo6I8(OCOCF3)(6)], efficiently absorb X-rays due to the high content of heavy elements, leading to the formation of the excited triplet states that interact with molecular oxygen to produce O-2((1)Delta(g)). The activity of the nanoparticles on HeLa cells was first investigated under UVA/blue-light irradiation in order to prove the biological effects of photosensitized O-2((1)Delta(g)), there is no dark toxicity at micromolar concentrations, but strong phototoxicity in the nanomolar range. The nanoparticles significantly enhance the antiproliferative effect of X-ray radiation in vitro at lower concentration than for previously reported O-2((1)Delta(g)) radiosensitizing systems and this effect is more pronounced on cancer HeLa cells than non-cancer MRC cells. The results demonstrate that the clusterbased radiosensitizers of O-2((1)Delta(g)) have strong potential with respect to the enhancement of the efficacy of radiotherapy with exciting opportunities for cancer treatment.
Název v anglickém jazyce
Octahedral molybdenum clusters as radiosensitizers for X-ray induced photodynamic therapy
Popis výsledku anglicky
The use of radiosensitizers recently emerged as a promising approach to circumvent the depth penetration limitations of photodynamic therapy of cancer and to enhance radiotherapeutical effects. A widely explored current strategy is based on complex nanoarchitectures that facilitate the transfer of energy harvested from X-ray radiation by scintillating nanoparticles to the surrounding photosensitizer molecules to generate reactive oxygen species, mostly singlet oxygen O-2((1)Delta(g)). We describe an alternative approach aiming at a considerable simplification of the architecture. The presented nanoparticles, made of the luminescent octahedral molybdenum cluster compound (n-Bu4N)(2)[Mo6I8(OCOCF3)(6)], efficiently absorb X-rays due to the high content of heavy elements, leading to the formation of the excited triplet states that interact with molecular oxygen to produce O-2((1)Delta(g)). The activity of the nanoparticles on HeLa cells was first investigated under UVA/blue-light irradiation in order to prove the biological effects of photosensitized O-2((1)Delta(g)), there is no dark toxicity at micromolar concentrations, but strong phototoxicity in the nanomolar range. The nanoparticles significantly enhance the antiproliferative effect of X-ray radiation in vitro at lower concentration than for previously reported O-2((1)Delta(g)) radiosensitizing systems and this effect is more pronounced on cancer HeLa cells than non-cancer MRC cells. The results demonstrate that the clusterbased radiosensitizers of O-2((1)Delta(g)) have strong potential with respect to the enhancement of the efficacy of radiotherapy with exciting opportunities for cancer treatment.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10402 - Inorganic and nuclear chemistry
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2018
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Materials Chemistry B
ISSN
2050-750X
e-ISSN
—
Svazek periodika
6
Číslo periodika v rámci svazku
26
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
7
Strana od-do
4301-4307
Kód UT WoS článku
000437470100003
EID výsledku v databázi Scopus
2-s2.0-85049638622